|
Partnership for Tuberculosis (TB) and TB/HIV Research -2
|
Resource Development
|
CDC
|
NIAID
|
Support for whole genome sequencing (WGS) of isolates and bioinformatics/analytic support for WGS to characterize TB drug resistance mutations. This is a joint CDC/NIAID effort to develop a comprehensive database of resistance polymorphisms and phenotypic correlations from clinical samples from various sites worldwide.
|
|
Partnerships for Accelerating Cancer Therapies (PACT)
|
Other
|
FDA
|
OD/OSP, NCI
|
The Partnership for Accelerating Cancer Therapies (PACT) is a public-private partnership between NIH, FDA, the private sector, foundations, and cancer advocacy organizations to accelerate progress in cancer research and bring cancer therapies to patients in less time as part of the Cancer Moonshot. Following in the models of successful existing partnerships, PACT will support jointly funded research through a collaborative decision making structure and ensure open data sharing with partners and the public.
|
|
Pathogen Detection Project
|
Resource Development
|
CDC, FDA
|
NLM
|
The Pathogen Detection Project is a multi-agency collaboration that is combining data from pathogen outbreaks with other information to determine the major source of contamination. The project is conducted via a centralized system that integrates sequence data for bacterial pathogens obtained from food, the environment, and human patients. A number of public health agencies in the US and internationally are collecting samples from these sources to facilitate active, real-time surveillance of pathogens and foodborne disease. The agencies sequence the samples and submit the data to NCBI/NLM/NIH, which analyzes the sequences against others in its database to identify closely related sequences. The aim is to uncover potential sources of contamination by linking isolates from food or the environment to human illness and to quickly report the sequence relationships to public health scientists in order to aid trace back investigations and outbreak response. Collaborating agencies include FDA, CDC, USDA-Food Safety and Inspection Service, and Public Health England.
|
|
Pathways to Prevention (P2P)
|
Meeting/ Workshop
|
AHRQ
|
OD/DPCPSI/ODP
|
The Pathways to Prevention (P2P) program is a workshop series hosted by the Office of Disease Prevention to identify research gaps in a selected scientific area, identify methodological and scientific weaknesses in that scientific area, suggest research needs, and move the field forward through an unbiased, evidence-based assessment of a complex public health issue. P2P workshops are designed for topics that have incomplete or underdeveloped research and for which it is difficult to produce a report synthesizing published literature.
|
|
Patient-Centered Outcomes Research Clinical Decision Support Learning Network (PCOR CDS-LN) Advisory Council
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, OS
|
NLM
|
Provide forum for stakeholders to assess both barriers and facilitators to implementing PCOR findings in CDS and make recommendations for optimizing PCOR-enabled CDS to facilitate improvements in care and outcomes.The PCOR CDS-LN is funded through a cooperative agreement with the Agency for Healthcare Research and Quality
|
|
Pediatric-PMTCT PEPFAR Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD
|
The Pediatric-PMTCT PEPFAR working group supports the objectives of the U.S. President''s Emergency Plan for AIDS Relief (PEPFAR) and prevention of mother-to-child transmission (PMTCT).
Beginning with the President''s Mother and Child HIV Transmission Initiative in 2002, and then expanding with the launch of the U.S. President''s Emergency Plan for AIDS Relief (PEPFAR) in 2003, prevention of mother-to-child transmission (PMTCT) has been a central focus of U.S. Government global HIV/AIDS efforts. Congress established the Expert Panel on Prevention of Mother-to-Child Transmission of HIV in Section 309 of H.R. 5501, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008. Its purposes are to provide an objective review of PEPFAR''s PMTCT activities, and provide recommendations to the U.S. Global AIDS Coordinator and the appropriate Congressional committees for further scale-up of services to achieve the ambitious target of reaching 80 percent of pregnant women in countries most affected by HIV/AIDS in which the U.S. has HIV/AIDS programs.
|
|
Pertussis Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
The objective of the Pertussis Working Group is to share information and promote collaborations among U.S. Department of Health and Human Services (HHS) agencies in order to better understand the recent resurgence of pertussis in the U. S. and identify potential strategies to address the problem.
|
|
PhenX Tobacco Regulatory Research (TRR) Working Groups
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIDA, OD/DPCPSI/ODP
|
The FDA and the NIH Tobacco Regulatory Science Program (TRSP) are seeking to expand the depth and breadth of tobacco-related measures that can enhance cross-study analysis in large-scale research. Use of the selected consensus measures will facilitate the comparison of results from different studies and the combination of studies to create larger sample sizes, increasing statistical power and the ability to detect more subtle and complex associations. The measures will be housed within the PhenX Toolkit (https://www.phenxtoolkit.org/). PhenX is a repository for measures identified as central in a field, developed with funding from the NHGRI.
|
|
PhysicalAactivity and Healthcare Utilization and Costs in Older Adults
|
Research Initiative
|
CDC
|
NCI
|
Through this initiative, CDC and NCI plan to investigate the association between physical activity over the life-course on later life health care utilization and costs in Medicare recipeients in the AARP Cohort.
|
|
Pink Ribbon Red Ribbon
|
Meeting/ Workshop
|
CDC
|
NCI
|
Pink Ribbon Red Ribbon (PRRR) is a partnership to leverage public and private sector investments to address breast and cervical cancers in developing countries. It is being implemented in several countries in sub-Saharan Africa. The National Cancer Institute and Centers for Disease Control and Prevention provide technical assistance in implementation strategies to the PRRR countries. This assistance involves drafting guidelines for monitoring and evaluation of prevention and treatment services as well as developing communication strategies.
|